What is enGene Therapeutics Inc.?
, through its subsidiary enGene, Inc.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, through its subsidiary enGene, Inc. , operates as a clinical-stage biotechnology company in Canada. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 117.28M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.